Effect of the Protonation State of the Titratable Residues on the Inhibitor Affinity to BACE-1

被引:52
作者
Dominguez, Jose L. [2 ]
Christopeit, Tony [1 ]
Carmen Villaverde, M. [2 ]
Gossas, Thomas [1 ]
Otero, Jose M. [2 ]
Nystrom, Susanne [3 ]
Baraznenok, Vera [3 ]
Lindstrom, Erik [3 ]
Danielson, U. Helena [1 ]
Sussman, Fredy [2 ]
机构
[1] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden
[2] Univ Santiago de Compostela, Dept Quim Organ, Fac Quim, Santiago De Compostela 15782, Spain
[3] Medivir AB, Huddinge, Sweden
关键词
AMYLOID PRECURSOR PROTEIN; MEMAPSIN-2; BETA-SECRETASE; STRUCTURE-BASED DESIGN; X-RAY CRYSTALLOGRAPHY; ASPARTYL PROTEASE; BINDING; POTENT; SITE; IDENTIFICATION; DISCOVERY;
D O I
10.1021/bi100637n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BACE-1 is one of the aspartic proteases involved in the cleavage of beta amyloid peptide, an initial step in the formation of amyloid plaques whose toxicity induces neuron death in Alzheimer's disease patients. One of the central issues in the search of novel BACE-I inhibitors is the optimum pH for the binding of inhibitors to the enzyme. It is known that the enzyme has optimal catalytic activity at acidic pH, while cell active inhibitors may bind optimally at higher pH. In this work we determine the effect of the pH on the affinities of a set of inhibitors, with a variety of chemical motifs, for the ectodomain region of RACE-I by a surface plasmon resonance (SPR) biosensor based assay. In order to understand the molecular interactions that underlie the diverse optimum pH for the binding of the various inhibitors as observed experimentally, We have calculated the titration curves for a set of BACE-1 ligand complexes. The results indicate that the pK(a),, values of the titratable residues of the protein depend on the nature of the ligand involved, in disagreement with previous work. The enzyme-inhibitor structures with the resulting protonation states at pH values 4.5 and 7.4 served as the starting point for the prediction of the pH-dependent binding ranking. Our calculations reproduced the entire affinity ranking observed upon pH increase and most of the binding trends among inhibitors, especially at low pH. Finally, our cell-based assays indicate a possible correlation between high inhibitor affinity at both acidic and neutral pH values, with optimal cell response, a result that may open new venues for the search of potent BACE-1 inhibitors that are active at the cellular level.
引用
收藏
页码:7255 / 7263
页数:9
相关论文
共 35 条
[1]   Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: Exploration of P1 phenoxy and benzyloxy residues [J].
Back, Marcus ;
Nyhlen, Jonas ;
Kvarnstrom, Ingemar ;
Appelgren, Sara ;
Borkakoti, Neera ;
Jansson, Katarina ;
Lindberg, Jimmy ;
Nystrom, Susanne ;
Hallberg, Anders ;
Rosenquist, Asa ;
Samuelsson, Bertil .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (21) :9471-9486
[2]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[3]   Second generation of hydroxyethylamine BACE-1 inhibitors: Optimizing potency and oral bioavailability [J].
Charrier, Nicolas ;
Clarke, Brian ;
Cutler, Leanne ;
Demont, Emmanuel ;
Dingwall, Colin ;
Dunsdon, Rachel ;
East, Philip ;
Hawkins, Julie ;
Howes, Colin ;
Hussain, Ishrut ;
Jeffrey, Phil ;
Maile, Graham ;
Matico, Rosalie ;
Mosley, Julie ;
Naylor, Alan ;
O'Brien, Alistair ;
Redshaw, Sally ;
Rowland, Paul ;
Soleil, Virginie ;
Smith, Kathrine J. ;
Sweitzer, Sharon ;
Theobald, Pam ;
Vesey, David ;
Walter, Daryl S. ;
Wayne, Gareth .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (11) :3313-3317
[4]   MUTATION OF THE BETA-AMYLOID PRECURSOR PROTEIN IN FAMILIAL ALZHEIMERS-DISEASE INCREASES BETA-PROTEIN PRODUCTION [J].
CITRON, M ;
OLTERSDORF, T ;
HAASS, C ;
MCCONLOGUE, L ;
HUNG, AY ;
SEUBERT, P ;
VIGOPELFREY, C ;
LIEBERBURG, I ;
SELKOE, DJ .
NATURE, 1992, 360 (6405) :672-674
[5]   The catalytic mechanism of an aspartic proteinase explored with neutron and X-ray diffraction [J].
Coates, Leighton ;
Tuan, Han-Fang ;
Tomanicek, Stephen ;
Kovalevsky, Andrey ;
Mustyakimov, Marat ;
Erskine, Peter ;
Cooper, Jon .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (23) :7235-+
[6]   Identification of a small molecule nonpeptide active site β-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases [J].
Coburn, CA ;
Stachel, SJ ;
Li, YM ;
Rush, DM ;
Steele, TG ;
Chen-Dodson, E ;
Holloway, MK ;
Xu, M ;
Huang, Q ;
Lai, MT ;
DiMuzio, J ;
Crouthamel, MC ;
Shi, XP ;
Sardana, V ;
Chen, ZG ;
Munshi, S ;
Kuo, L ;
Makara, GM ;
Annis, DA ;
Tadikonda, PK ;
Nash, HM ;
Vacca, JP ;
Wang, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6117-6119
[7]   Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 2. Computational titration and pH effects in molecular models of neuraminidase-inhibitor complexes [J].
Fornabaio, M ;
Cozzini, P ;
Mozzarelli, A ;
Abraham, DJ ;
Kellogg, GE .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (21) :4487-4500
[8]   Potent memapsin 2 (β-secretase) inhibitors:: Design, synthesis, protein-ligand X-ray structure, and in vivo evaluation [J].
Ghosh, Arun K. ;
Kumaragurubarana, Nagaswamy ;
Hong, Lin ;
Kulkarni, Sarang ;
Xu, Xiaoming ;
Miller, Heather B. ;
Reddy, Dandepally Srinivasa ;
Weerasena, Vajira ;
Turner, Robert ;
Chang, Wanpin ;
Koelsch, Gerald ;
Tang, Jordan .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) :1031-1036
[9]   Harnessing Nature's Insight: Design of Aspartyl Protease Inhibitors from Treatment of Drug-Resistant HIV to Alzheimer's Disease' [J].
Ghosh, Arun K. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) :2163-2176
[10]   Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimetics [J].
Hanessian, S ;
Yun, HY ;
Hou, YH ;
Yang, GQ ;
Bayrakdarian, M ;
Therrien, E ;
Moitessier, N ;
Roggo, S ;
Veenstra, S ;
Tintelnot-Blomley, M ;
Rondeau, JM ;
Ostermeier, C ;
Strauss, A ;
Ramage, P ;
Paganetti, P ;
Neumann, U ;
Betschart, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) :5175-5190